Mind Medicine (MindMed) Inc
NASDAQ:MNMD

Watchlist Manager
Mind Medicine (MindMed) Inc Logo
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
Watchlist
Price: 7.32 USD 3.39%
Market Cap: 536.8m USD
Have any thoughts about
Mind Medicine (MindMed) Inc?
Write Note

Mind Medicine (MindMed) Inc
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Mind Medicine (MindMed) Inc
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
Total Current Liabilities
$33.3m
CAGR 3-Years
79%
CAGR 5-Years
219%
CAGR 10-Years
N/A
Bausch Health Companies Inc
TSX:BHC
Total Current Liabilities
$4.5B
CAGR 3-Years
-6%
CAGR 5-Years
4%
CAGR 10-Years
4%
Canopy Growth Corp
TSX:WEED
Total Current Liabilities
CA$281.3m
CAGR 3-Years
3%
CAGR 5-Years
-8%
CAGR 10-Years
62%
Sundial Growers Inc
NASDAQ:SNDL
Total Current Liabilities
CA$103.1m
CAGR 3-Years
62%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Cronos Group Inc
TSX:CRON
Total Current Liabilities
$39.6m
CAGR 3-Years
-17%
CAGR 5-Years
-39%
CAGR 10-Years
N/A
C
Curaleaf Holdings Inc
CNSX:CURA
Total Current Liabilities
$556.2m
CAGR 3-Years
46%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Mind Medicine (MindMed) Inc
Glance View

Market Cap
536.8m USD
Industry
Pharmaceuticals

Mind Medicine (MindMed), Inc. operates as a neuro-pharmaceutical company that discovers, develops and deploys psychedelic medicines to improve health, promote wellness and alleviate suffering. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2015-05-04. The firm focuses on discovering, developing and deploying psychedelic-inspired medicines and therapies to address addiction and mental illness. The firm's commercial drug development programs includes lysergic acid diethylamide (LSD) experiential therapy, 18-methoxycoronaridine (18-MC) opioid withdrawal, LSD microdosing, methylenedioxymethamphetamine (MDMA), and dimethyltryptamine (DMT). The firm's subsidiaries include Mind Medicine, Inc., HealthMode, Inc., MindMed Pty Ltd. and MindMed GmbH.

MNMD Intrinsic Value
2.22 USD
Overvaluation 70%
Intrinsic Value
Price

See Also

What is Mind Medicine (MindMed) Inc's Total Current Liabilities?
Total Current Liabilities
33.3m USD

Based on the financial report for Sep 30, 2024, Mind Medicine (MindMed) Inc's Total Current Liabilities amounts to 33.3m USD.

What is Mind Medicine (MindMed) Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
219%

Over the last year, the Total Current Liabilities growth was 7%. The average annual Total Current Liabilities growth rates for Mind Medicine (MindMed) Inc have been 79% over the past three years , 219% over the past five years .

Back to Top